GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier-Reference-Cited by-同舟云学术

GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier

Published:2020-04-30 Issue:11 Volume:11 Page:1620-1633
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Arora Sanjay¹,Sharma Divya¹,Singh Jagdish¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy, College of Health Professions, North Dakota State University, Fargo, North Dakota 58105, United States

Funder

National Institute on Aging

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00076

Reference72 articles.

1. Nanotechnology for neurodegenerative disorders

2. 2009 Alzheimer's disease facts and figures

3. Modeling an Anti-Amyloid Combination Therapy for Alzheimer’s Disease

4. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

5. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier;International Journal of Pharmaceutics;2024-09

2. Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems;BioDrugs;2024-08-23

3. Causality between Sarcopenia and Depression: A Bidirectional Mendelian Randomization Study;Actas Españolas de Psiquiatría;2024-08-05

4. Dual-targeting liposomes modified with BTP-7 and pHA for combined delivery of TCPP and TMZ to enhance the anti-tumour effect in glioblastoma cells;Journal of Microencapsulation;2024-07-11

5. Blood pressure reduction through brain delivery of nanoparticles loaded with plasmid DNA encoding angiotensin receptor shRNA;Molecular Therapy - Nucleic Acids;2024-06